Varonis Systems VRNS Crushes Q2 2026 EPS by 506% as SaaS ARR Hits $726M
As seen on the 24/7 Wall St. homepage on July 28, 2026.
Varonis demolished EPS expectations by 506% while lifting full-year guidance on the back of a 52% surge in SaaS ARR, now at $726 million and accelerating toward the $1 billion target that analysts view as increasingly locked in.
Continue ReadingShow less
Varonis reported Q2 2026 earnings per share of $0.04 against a Wall Street estimate of roughly $0.007, a beat of more than 500%. Revenue came in at $180 million, topping the consensus estimate of about $177 million. The company also raised its full-year guidance, signaling that management sees the momentum as durable rather than a one-quarter fluke.
The standout metric driving that confidence is SaaS annual recurring revenue, which jumped 52% to $726 million. That figure matters because it measures the sticky, subscription-based portion of Varonis's business — the revenue stream investors care most about as the company completes its transition away from perpetual licenses. Analysts had already flagged $1 billion in SaaS ARR as a key milestone, and the pace of growth is making that target look increasingly reachable.
Sponsored
_________________________________
What's Your Number...?
Here's a question most people 5y from retirement can't answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset's free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)
__________________________________________
Looking at the last eight quarters, Varonis has beaten EPS estimates in every single period, including a $0.06 reported versus a negative $0.05 estimate in Q1 2026 and a $0.08 reported versus $0.03 estimated in Q4 2025. That consistent pattern of upside surprises gives the raised full-year guidance more credibility than a standalone beat might otherwise warrant.
Mentioned: VRNS